NURIX THERAPEUTICS, INC. (NRIX) EBITDA
NURIX THERAPEUTICS, INC. (NRIX) EBITDA
- 2026-05-31: Basis Reported; EBITDA (m); Operating income -$94.20M; Depreciation and amortization (m).
- 2026-02-28: Basis Reported; EBITDA (m); Operating income -$92.50M; Depreciation and amortization (m).
- 2025-08-31: Basis Reported; EBITDA (m); Operating income -$91.39M; Depreciation and amortization (m).
- 2025-05-31: Basis Reported; EBITDA (m); Operating income -$48.32M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-05-31 | Reported | (m) | -$94.20M | (m) | $9.04M | (m) | $1.94M* | -$96.57M* | (m) | $87.65M | (m) | -$271.00K |
|---|
| 2026-02-28 | Reported | (m) | -$92.50M | (m) | $6.25M | (m) | $1.04M | -$71.91M | (m) | $84.14M | (m) | $0.00 |
|---|
| 2025-08-31 | Reported | (m) | -$91.39M | (m) | $7.89M | (m) | $2.71M* | -$57.38M* | (m) | $86.12M | (m) | $0.00 |
|---|
| 2025-05-31 | Reported | (m) | -$48.32M | (m) | $44.06M | (m) | $2.67M* | -$63.16M* | (m) | $78.10M | (m) | $760.00K |
|---|
| 2025-02-28 | Reported | (m) | -$62.86M | (m) | $18.45M | (m) | $3.48M | -$61.09M | (m) | $69.66M | (m) | $0.00 |
|---|
| 2024-08-31 | Reported | (m) | -$54.61M | (m) | $12.59M | (m) | $2.35M* | -$42.18M* | (m) | $55.48M | (m) | $82.00K |
|---|
| 2024-05-31 | Reported | (m) | -$48.54M | (m) | $12.09M | (m) | $1.94M* | -$39.70M* | (m) | $48.92M | (m) | $90.00K |
|---|
| 2024-02-29 | Reported | (m) | -$45.22M | (m) | $16.59M | (m) | $2.88M | -$41.95M | (m) | $50.01M | (m) | $90.00K |
|---|
| 2023-08-31 | Reported | (m) | -$40.01M | (m) | $18.47M | (m) | $2.46M* | -$41.13M* | (m) | $47.86M | (m) | $0.00 |
|---|
| 2023-05-31 | Reported | (m) | -$26.77M | (m) | $30.68M | (m) | $1.08M* | -$18.47M* | (m) | $45.76M | (m) | $0.00 |
|---|
| 2023-02-28 | Reported | (m) | -$42.95M | (m) | (m) | (m) | $2.28M | -$48.45M | (m) | $45.82M | (m) | $0.00 |
|---|
| 2022-08-31 | Reported | (m) | -$46.72M | (m) | (m) | (m) | $3.42M* | -$46.31M* | (m) | $47.76M | (m) | $0.00 |
|---|
| 2022-05-31 | Reported | (m) | -$45.72M | (m) | (m) | (m) | $2.79M* | -$32.91M* | (m) | $47.49M | (m) | $0.00 |
|---|
| 2022-02-28 | Reported | (m) | -$42.74M | (m) | (m) | (m) | $3.47M | -$42.63M | (m) | $43.14M | (m) | $0.00 |
|---|
| 2021-08-31 | Reported | (m) | -$29.00M | (m) | (m) | (m) | $1.86M* | -$29.97M* | (m) | $30.91M | (m) | -$123.00K |
|---|
| 2021-05-31 | Reported | (m) | -$26.41M | (m) | (m) | (m) | $2.09M* | -$31.54M* | (m) | $25.99M | (m) | $139.00K |
|---|
| 2021-02-28 | Reported | (m) | -$24.52M | (m) | (m) | (m) | $843.00K | $8.05M | (m) | $23.00M | (m) | $71.00K |
|---|
| 2020-08-31 | Reported | (m) | -$19.19M | (m) | (m) | (m) | $1.67M* | -$6.14M* | (m) | $18.94M | (m) | $0.00 |
|---|
| 2020-05-31 | Reported | (m) | -$13.23M | (m) | (m) | (m) | $1.61M* | -$14.43M* | (m) | $14.14M | (m) | -$20.59M |
|---|
| 2020-02-29 | Reported | (m) | -$12.55M | (m) | (m) | (m) | $364.00K | $40.97M | (m) | $12.97M | (m) | $11.00K |
|---|
| 2019-08-31 | Reported | (m) | -$2.61M | (m) | (m) | (m) | (m) | (m) | (m) | $11.01M | (m) | $10.00K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-11-30 | Reported | (m) | -$285.67M | (m) | $83.98M | (m) | $14.00M | -$249.47M | (m) | $316.90M | (m) | $760.00K |
|---|
| 2024-11-30 | Reported | (m) | -$213.03M | (m) | $54.55M | (m) | $9.27M | -$172.58M | (m) | $221.63M | (m) | $270.00K |
|---|
| 2023-11-30 | Reported | (m) | -$155.06M | (m) | $76.99M | (m) | $8.40M | -$81.36M | (m) | $189.15M | (m) | $0.00 |
|---|
| 2022-11-30 | Reported | (m) | -$183.87M | (m) | $38.63M | (m) | $12.24M | -$159.81M | (m) | $184.50M | (m) | $0.00 |
|---|
| 2021-11-30 | Reported | (m) | -$117.89M | (m) | (m) | (m) | $5.66M | -$84.36M | (m) | $116.43M | (m) | $131.00K |
|---|
| 2020-11-30 | Reported | (m) | -$64.98M | (m) | (m) | (m) | $4.55M | -$80.00K | (m) | $66.49M | (m) | -$20.54M |
|---|
| 2019-11-30 | Reported | (m) | -$22.24M | (m) | (m) | (m) | $1.65M | $601.00K | (m) | $45.02M | (m) | $239.00K |
|---|